Reviva Pharmaceuticals Newsroom

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Moomoo NewsNov 16 10:31 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaNov 15 06:26 ET

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow JonesNov 14 17:25 ET

Reviva Pharm Holdings Price Target Maintained With a $15.00/Share by D. Boral Capital

Dow JonesNov 14 17:25 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaNov 13 18:08 ET

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $15 Price Target

BenzingaNov 13 18:08 ET

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Moomoo NewsNov 13 15:31 ET

Maxim Group Keeps Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)

TipRanksNov 13 15:17 ET

Reviva Pharm Holdings Price Target Announced at $15.00/Share by EF Hutton

Dow JonesSep 23 08:46 ET

Reviva Pharm Holdings Initiated at Buy by EF Hutton

Dow JonesSep 23 08:46 ET

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Moomoo NewsSep 6 13:31 ET

Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)

TipRanksSep 6 12:37 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 26 09:56 ET

Maxim Group Downgrades Reviva Pharmaceuticals(RVPH.US) to Hold Rating

Moomoo NewsAug 16 08:31 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 16 08:04 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJul 11 06:34 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 20 06:15 ET

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

BenzingaJun 20 06:15 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 11 06:17 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaMay 28 08:22 ET